Medicinova Inc (MNOV) Stock Price, Quote & News

Company Profile

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical my...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 373 1500

Fax: 858 404 0048

Website: medicinova.com

Address:

4275 Executive Square, Suite 300, La Jolla, United States

SuperGreenToday Dec. 26 at 3:52 PM

$MNOV Share Price: $1.24 Contract Selected: Jul 17, 2026 $2.5 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.09 Potential Upside: 59% ROI Time to Expiration: 202 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

LimeLightL Dec. 25 at 9:37 AM

$MNOV Expectations reset as evidence replaces narrative, given the heightened sensitivity to timeline slippage. Shortfalls would likely reprice expectations quickly.

1 · Reply

prismmarketview Dec. 18 at 4:11 PM

MediciNova (NASDAQ: $MNOV ) has completed enrollment in its investigator‑initiated Phase 2 OXTOX trial evaluating MN‑166 (ibudilast) to prevent chemotherapy‑induced peripheral neuropathy in metastatic colorectal cancer, with 100 patients randomized across 11 Australian sites and top‑line data expected in late 2026 after six‑month post‑chemo follow‑up. https://prismmarketview.com/medicinova-completes-enrollment-in-phase-2-study-of-mn-166-for-chemotherapy-induced-neuropathy/

0 · Reply

JarvisFlow Dec. 18 at 1:00 PM

D. Boral Capital has updated their rating for MediciNova ( $MNOV ) to Buy with a price target of 9.

0 · Reply

DARKP00L Dec. 18 at 11:13 AM

$MNOV 06:08 on Dec. 18 2025 MediciNova Completes Patient Enrollment in Mid-Stage Trial for Chemotherapy Nerve Damage #tradeideas

0 · Reply

Susiita81 Dec. 12 at 12:20 PM

$MNOV NEW!!! Ibudilast for Parkinson's disease https://onlinelibrary.wiley.com/doi/10.1111/jnc.70321

0 · Reply

thepalace2007 Dec. 11 at 3:02 PM

$MNOV keep accumulating this will fly $7 price target

1 · Reply

Jabbar19 Dec. 9 at 11:10 AM

$MNOV what is behind this repeated price target news by D. Boral Capital? "MediciNova Price Target Maintained With a $9.00/Share by D. Boral Capital".

1 · Reply

JarvisFlow Dec. 8 at 4:17 PM

D. Boral Capital updates rating for MediciNova ( $MNOV ) to Buy, target set at 9.

0 · Reply